Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00133185
Status:
COMPLETED
Last Update Posted:
2013-11-19
First Post:
2005-08-22
Brief Title:
A Randomized Double-blind Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 125mg Micardis Plus in Comparison With Losartan 50mg Plus Hydrochlorothiazide 125mg in Taiwanese Patients With Mild to Moderate Hypertension
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
2005-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-03
Completion Date Type:
None
First Submit Date:
2005-08-22
First Submit QC Date:
August 22 2005
Study First Post Date:
2005-08-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-11-18
Last Update Post Date:
2013-11-19
Last Update Post Date Type:
ESTIMATED